Skip to content

Investigation of the Performance and Safety of New 1-piece Open Ostomy Appliances Compared to Standard Care

An Open-labelled, Randomized, Controlled, Comparative, Single Country (Denmark), Explorative, Cross-over Study Investigating the Performance and Safety of New 1-piece Open Ostomy Appliances Compared to Standard Care 1-piece Open Ostomy Appliances in 25 Subjects With Ileostomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01957384
Enrollment
25
Registered
2013-10-08
Start date
2012-02-29
Completion date
2012-05-31
Last updated
2014-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy - Stoma

Brief summary

To assess the functionality and safety of the test products and also assess the products' ability to collect stool without interfering with the stoma. The degree of leakage using the product will also be measured

Interventions

Coloplast Test product 1 is a new ostomy appliance developed by Coloplast.

Coloplast Test product 2 is a new ostmoy appliance developed by Coloplast A/S

DEVICEStandard Care (Coloplast SenSura; Dansac Nova 1; Hollister Moderma FLex; Convatec Esteem; B.Braun Flexima Active)

Standard Care was the subject usual ostomy appliance and had to be one of the following: * Coloplast: SenSura, 1-piece open bag without inspection window, size midi and maxi, custom-cut, * Dansac: Nova 1 & Nova Life, 1-piece open bag, size midi and maxi, custom-cut baseplate * Hollister: Moderma Flex, 1-piece open, size midi and maxi, custom-cut baseplate * ConvaTec: Esteem, 1-piece open bag, size midi and maxi, custom-cut baseplate * B. Braun: Flexima Active & Softima, 1-piece open bag, size midi and maxi, custom-cut baseplate

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have given written informed consent * Be at least 18 years of age and have full legal capacity * Be able to handle the bags themselves or with help from caregiver * Have an ileostomy with a diameter between 15 and 45 mm * Have had their ostomy for at least three months * Currently use a 1-piece flat standard care product with open bag * Negative result of a pregnancy test for women of childbearing age * Custom-cut product user * Be suitable for participation in the investigation

Exclusion criteria

* Use irrigation during the study (flush the stoma with water) * Currently receiving or have within the past 2 months received radio- and/or chemotherapy * Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area * Are pregnant or breastfeeding * Participating in other interventional clinical investigations or have previously participated in this investigation * Max three days wear time * Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)

Design outcomes

Primary

MeasureTime frameDescription
Degree of LeakageUp to 14 days per test productThe degree of leakage was measured on a 24-point scale 0 (best possible outcome) to 24 (worst possible outcome) developed by Coloplast A/S

Countries

Denmark

Participant flow

Recruitment details

The subjects were recruited through the Coloplast database in Denmark

Pre-assignment details

25 subjects signed informed consent and were randomized. 2 subjects were screening failures and did not test any products. One subject violated an inclusion criterion (convex user). The subject tested both test products and is therefore included in the safety population. The 3 subjects are not included in the participant flow below.

Participants by arm

ArmCount
All Subjects24
Total24

Baseline characteristics

CharacteristicAll Subjects
Age, Continuous28.4 years
STANDARD_DEVIATION 10.9
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
5 / 226 / 223 / 22
serious
Total, serious adverse events
1 / 220 / 220 / 22

Outcome results

Primary

Degree of Leakage

The degree of leakage was measured on a 24-point scale 0 (best possible outcome) to 24 (worst possible outcome) developed by Coloplast A/S

Time frame: Up to 14 days per test product

ArmMeasureValue (MEAN)Dispersion
Coloplast Test Product 1Degree of Leakage4 units on a scaleStandard Deviation 5
Coloplast Test Product 2Degree of Leakage4.6 units on a scaleStandard Deviation 5.6
Standard CareDegree of Leakage2.6 units on a scaleStandard Deviation 3.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026